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Abstract 
Initiation of apoptosis, or programmed cell death, is an important issue in cancer 
treatment as cancer cells frequently have acquired the ability to block apoptosis and thus 
are more resistant to chemotherapeutic drugs.  Targeted and perhaps selective destruction 
of cancerous tissue is desirable for many reasons, ranging from the enhancement of or aid 
to current medical methods to problems currently lacking a solution, i.e. lung cancer.  
Demonstrated in this publication is the inactivation (killing) of human Melanoma skin 
cancer cell lines, in vitro, by Floating Electrode Dielectric Barrier Discharge plasma.  Not 
only are these cells shown to be killed immediately by high doses of plasma treatment, 
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but low doses are shown to promote apoptotic behavior as detected by TUNEL staining 
and subsequent flow cytometry.  It is shown that plasma acts on the cells directly and not 
by “poisoning” the solution surrounding the cells, even through a layer of such solution.  
Potential mechanisms of interaction of plasma with cells are discussed and further steps 
are proposed to develop an understanding of such systems. 
 
1. Introduction 
Apoptosis, or programmed cell death, is a complex biochemical process of controlled 
self-destruction of a cell in a multicellular organism [1, 2].  This process plays an 
important role in maintaining tissue homeostasis, fetal development, immune cell 
“education”, development, and aging.  Examples of apoptosis that occur during normal 
body processes include the formation of the outer layer of skin, the inner mucosal lining 
of the intestine, and the endometrial lining of the uterus, which is sloughed off during 
menstruation.  During apoptosis, cellular macromolecules are digested into smaller 
fragments in a controlled fashion, and ultimately the cell collapses into smaller intact 
fragments that can be removed by phagocytosis without damaging the surrounding cells 
or causing inflammation.  In contrast, during necrosis, also termed “accidental cell 
death”, the cell bursts and the cellular contents spill out into the extracellular space, 
which can cause inflammation.  Necrosis is induced by cellular injury, for example, 
extreme changes in osmotic pressure or heat, that lead to adenosine tri-phosphate (ATP) 
depletion of the cell.  With cancer cells, however, a problem arises with apoptosis as the 
tumor cells frequently “learn” how to turn off apoptosis as one of the processes they 
employ in evading the immune system and surviving under unfavorable conditions.  For 
this reason, for example, chemotherapy as means of treatment of breast, colon, and lung 
cancer met limited success [1].  In general, the employment of systemic chemotherapy 
drugs to induce apoptosis in cells that try to block it is not an easy task, as these drugs 
tend to affect all cells in the body [1, 2].  A way to target apoptosis development only in 
specific areas of the body is needed and a method to do so is offered in this paper where 
apoptotic behavior is promoted in Melanoma cancer cell lines following low doses of 
non-thermal plasma treatment insufficient to destroy the cell immediately. 
In recent years, non-thermal plasma discharges have been gaining popularity in the 
materials processing industry for their ability to selectively modify a surface with 
minimal, if any, damage to this surface and practically no change to the bulk material.  
This way, for example, a surface of an implant may be made biologically compatible to 
the tissues and cells it will come in contact with, while the bulk material of the implant 
can be tailored to desirable mechanical properties like high strength, low weight, 
durability, fracture resistance, etc.  Recently, the demand for sterilization and disinfection 
of various surfaces increased and non-thermal plasmas were found to be an effective 
solution.  Many groups worldwide have successfully demonstrated plasma’s ability to 
treat, disinfect, and sterilize various targets.  Plasmas are widely used in textile [3-5] and 
lighting industries [6-8], electronics [8-11], and in many other applications (see [8-12], 
for example).  It is no surprise that biology and medicine also employ the “fourth state of 
matter” in materials processing [13-15], sterilization [10, 16-23], improvement of bio-
compatibility [13, 24, 25], tissue engineering [26-28], to increase adhesion and 
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wettability and for other surface modifications [29-34].  Medical applications focused on 
plasma treatment of living tissue, which are of growing interest these days, require 
treatments at atmospheric pressure since cells and tissues are not vacuum-compatible [16, 
35].  Atmospheric pressure treatments can be separated into two major categories: where 
temperature is used as means of treatment [36-40], and where active species, radicals, or 
ultraviolet radiation generated by plasma are used for targeted chemical modification and 
catalysis [8, 10, 16, 41-48].  Thermal plasmas are widely used in medicine today both in 
attached arc mode where arc contacts the tissue directly [40, 49-51] and in a “jet” mode 
where gas (usually argon) is blown through the plasma but remains at high temperature 
[36, 37, 39, 52].  Both attached arc and thermal jet are known and used for their ability to 
rapidly coagulate blood [36, 37, 39, 40, 50, 52]; however, they can cause significant 
thermal tissue desiccation, burning, and eschar formation1.  Additionally, excessive 
smoke could be a problem during thermal treatment of tissues.  During open-air 
treatments smoke can be removed by means of vacuum suction (though it is not a simple 
procedure); however, during endoscopic treatments smoke becomes a major issue where 
it is very difficult to remove and obstructs the view of the camera.  For these reasons, 
development of non-thermal plasma methods of treatment where temperature does not 
exceed 60 °C is needed. 
Recently, the focus of the plasma community has shifted to applications where tissue 
damage and desiccation are minimized or eliminated [35].  Many configurations have 
been proposed for treatment of biological surfaces, cells, and tissues.  The “plasma 
needle,” for example, can possibly be used for selective cell detachment [28, 30, 45].  It 
involves a corona discharge igniting at the end of a sharp tip in helium upon application 
of radio frequency (~13 MHz) electromagnetic excitation.  This discharge operates at 
near room temperature, dissipating milliwatts in several cubic millimeters.  Suggested 
applications for this technique include treatment of dental cavities and skin disorders.  
This plasma has been demonstrated to destroy cells and bacteria in a highly localized 
fashion without disrupting the nearby tissue [45].  Recently it was also shown that this 
plasma promotes inactivation in mouse fibroblast cells, where apoptosis-like behavior is 
observed after treatment – the cells appear to clump up and die [53].  Another promising 
use of non-thermal plasmas is reversible pore formation for targeted drug delivery [28, 
30] or irreversible pore formation [30, 54].  Pulsed Electron Avalanche Knife (PEAK) is 
one more plasma-based surgical tool where thermal damage to tissue is reduced by 
keeping the current pulses short (microseconds) and the electrodes thin (microns).  Even 
though the device operates in the high current regime, timescales of treatment are not 
enough to heat up the tissue, resulting in non-damaging treatment [55, 56].  PEAK was 
successfully demonstrated in precise cutting with minimal damage.  However, these 
systems are designed for precise treatment or cutting of very small areas and another 
system, capable of treating large areas of living tissue, is discussed in this paper.  The 
Floating Electrode Dielectric Barrier Discharge (FE-DBD) system, constructed similarly 
to conventional dielectric barrier discharges is inherently non-thermal – it is able to 
operate at room temperature and pressure [10, 57].  This system operates at power 
densities of 0.1 to 2 Watts/cm2.  FE-DBD was applied for complete skin sterilization 
                                                 
1 In medicine, the term “eschar” describes a slough or dry scab that forms on an area of skin that has been 
burnt or exposed to corrosive agents.  The term “eschar” is commonly confused with “char”. 
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without any damage to skin and blood coagulation without damage to surrounding tissue 
[16]. 
Presented in this paper is a way to treat cells where immediate destruction and necrosis is 
not desired or directly achieved by plasma.  FE-DBD plasma treatment is shown to 
initiate apoptosis in Melanoma cancer cell lines – a threshold at which plasma treatment 
does not cause immediate necrosis but initiates complex cascade of biochemical 
processes leading to cell death many hours and even days following the treatment.  
Melanoma cells, treated by plasma at doses significantly below those required for cell 
destruction, survive the plasma treatment but develop apoptosis many hours post 
treatment and die (disintegrate) by themselves gracefully.  This could potentially be an 
intriguing new idea for cancer treatment, especially if by manipulation of plasma 
parameters the treatment could be made selective to cancerous cells over healthy cells, as 
was demonstrated before for bacteria vs. healthy cells [16]. 
Following this introduction, Section 2 briefly discusses construction of the Floating 
Electrode DBD system used for the treatment.  Sections 3 and 4 present details of the 
biological preparations and experiments performed on Melanoma cancer cell lines 
including growing these cells, their life path, treatment dynamics, apoptosis assays, and 
flow cytometry.  Section 5 describes treatment of these cell lines for inactivation and 
necrosis, while Section 6 describes modes where the cells have not been inactivated by 
plasma but developed apoptosis many hours and days following the plasma treatment.  
This paper is concluded with ideas for future work to further analyze plasma-induced 
apoptosis mechanisms and their dependence on specific plasma-generated chemistry. 
2. Floating Electrode Dielectric Barrier Discharge 
In our experiments we apply continuous-wave high voltage (10 to 30 kV) to a quartz-
protected electrode that generates plasma between the quartz and the surface of living 
tissue of a human or animal, or a cell culture being treated (Figure 1).  Floating 
Electrode Dielectric Barrier Discharge (FE-DBD) operates under the conditions 
where one of the electrodes is a dielectric-protected powered electrode and the second 
active electrode is a human or animal skin or organ – without human or animal skin or 
tissue surface present discharge does not ignite [16].  In the FE-DBD setup, the second 
electrode (a human, for example) is not grounded and remains at a floating potential.  The 
principle of operation of the FE-DBD has been recently discussed in detail by the authors 
[16].  Of note is the fact that FE-DBD is completely safe from the electrical perspective 
and non-damaging for application to animal or human skin [16, 58].  Discharge ignites 
when the powered electrode approaches the surface to be treated at a distance (discharge 
gap) less than about 3 mm, depending on the form, duration, and polarity of the driving 
voltage. 
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Figure 1. Setup schematic for treatment of Melanoma cancer cells. 
Power deposited into plasma discharge gap was analyzed by measuring current passing 
through the discharge gap and the voltage drop in the gap.  For current measurements, a 
magnetic core Pearson current probe was utilized (1 V/Amp +1/-0% sensitivity, 10 ns 
usable rise time, 35 MHz bandwidth).  Voltage was measured using a wide bandwidth 
voltage probe (PVM-4 130 MHz 1000:1 <5% error, North Star High Voltage, Marana, 
AZ).  Signals from the current and voltage probes were acquired and recorded by a 
Digital Phosphor Oscilloscope (DPS) (500 MHz bandwidth, 5·109 samples/sec, 
TDS5052B, Tektronix, Inc.).  Acquired data was then processed using customized 
MATLAB code.  In all experiments presented in this paper the plasma power was kept at 
4 ±1 Watts, corresponding to power density of 0.8 ±0.2 Watt/cm2. 
3. Preparation and Treatment of Melanoma Skin Cancer Cells 
Melanoma cancer cell line (ATCC A2058) was propagated in Dulbecco's modified 
Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate 
and 4.5 g/L glucose, 90%, and fetal bovine serum, 10%.  Cells were incubated at 37 °C 
with 95% humidified air and 5% carbon dioxide (CO2).  The media was changed every 2-
3 days.  After 4-5 days of incubation the cells were detached from the dish surface by 
incubating in 0.25% weight/volume (w/v) Trypsin in 0.53 mM ethylene diamine 
tetraacetic acid (EDTA).  After detachment, trypsin was neutralized by FCS-containing 
growth medium. Cells were harvested by centrifugation and transferred to aluminum 
weighing dishes in dilution ratios of 1:5 to 1:6 where they were incubated as described 
above for 4-5 more days.  The number of cells in each dish at the end of incubation was 
about 1.5·106 on average. Viability of cultures was determined by Trypan blue exclusion 
(see below) to be 91-97% (Figure 2).  Control and treated cells are cultured in aluminum 
dishes and cell health is tightly monitored.  The aluminum dishes need to be thoroughly 
sterilized prior to the cell culturing procedures.  These dishes are sterilized by alcohol and 
then put in the high temperature autoclave for 3 hours at 350 °C where aluminum builds 
up a layer of oxide which prevents cells from contacting metal – this allows for higher 
number of cells to grow.  Prior to plasma treatment, media from each dish was removed 
completely and a small amount (200 µL) of fresh media was added to keep cells wet 
during treatment.  All experiments reported on in this paper were performed with 200 µL 
of media; separately, we have verified effect of plasma on these cells through a thicker 
layer of media (see Section 5 below and Figure 7).  Immediately following this 
procedure, the cells were treated with plasma for 5, 10, 15, 20, or 30 seconds.  The 
distance from the electrode surface to the fluid surface was 3 ±0.5 mm.  After the 
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treatment media was removed from the dishes, the culture was allowed to propagate 
further by adding 2 mL of the fresh media or harvested by trypsinization for further 
testing.   Trypsinized cells were scraped and collected in 15 mL tubes, centrifuged at 
1,000 rpm for 10 min at 4 °C.  Supernatants were removed and the cell pellet 
resuspended in 5 mL of 1X Phosphate Buffered Saline (PBS). 
For trypan blue exclusion, aliquots of the cell suspension were mixed with an equal 
volume of trypan blue (0.4% w/v in PBS, Cambrex Corp, Baltimore, MD) and transferred 
to a Hemocytometer slide.  Live cells with intact cell membrane exclude the dye and are 
unstained.  Total number of cells and percent of viable cells were determined by counting 
stained and unstained cells.  Trypan Blue exclusion test was performed at different time 
periods after treatment: immediately following treatment, 1, 3, 24, 48, and 72 hours 
following treatment. 
 
Figure 2. Growth pattern of Melanoma cancer cells in aluminum dishes. 
4. Apoptosis assay 
Another group of experiments was performed, testing cells for the onset of apoptosis.  
Cell propagation and plasma treatment were performed as above, except that the dose of 
plasma for this experiment was 5 seconds, as this dose was found to inactivate the least 
number of cells.  Following treatment, cells were harvested as above at 24, 48 and 72 
hours after treatment and DeadEnd™ Fluorometric TUNEL System apoptosis test was 
performed (Promega, Madison, WI) [59, 60].  This test detects apoptotic DNA 
fragmentation by catalytically incorporating fluorescein-12-dUTP(a) at 3´-OH DNA ends 
using the enzyme Terminal Deoxynucleotidyl Transferase (TdT), which forms a 
polymeric tail using the principle of the TUNEL (TdT-mediated dUTP Nick-End 
Labeling) assay.  The fluorescein-12-dUTP-labeled DNA can then be visualized directly 
by fluorescence microscopy or quantified by flow cytometry [59, 60].  For fluorescence 
microscopy, cells were fixed on Lab-Tek slides for the TUNEL assay. Samples were 
analyzed in a fluorescence microscope using a standard fluorescence filter set to view the 
green fluorescence of Fluorescein at 520 ±20 nm.  Both control and treated cells were 
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cultured in aluminum dishes to analyze the possibility of apoptosis developing from 
contact with aluminum.  Minimum levels of cell death were detected in control dishes 
that were not subjected to plasma (see Figure 2 for example). 
For flow cytometry analysis, cell suspensions were treated with the DeadEnd™ 
Fluorometric TUNEL System (Promega US Co), following the manufacturer’s 
instructions.  Counterstaining was done by incubating cells for 20 min at room 
temperature in the dark in phosphate-buffered saline containing 6 µg/ml RNAse (Roche 
Applies Sciences, Indianapolis, IN) and 5 µg/ml propidium iodide (Invitrogen, Carlsbad, 
CA) in PBS.  Suspensions were washed once in PBS and resuspended in PBS for 
analysis.  Flow cytometry was performed using a FACSORT flow cytometer (BD 
Biosciences, San Diego, CA) with 488 nm excitation from an argon ion laser at 15 mW.  
Forward scatter threshold was set to exclude small debris.  Fluorescein fluorescence was 
captured on the FL1 channel (Figure 11) equipped with a 530 nm wavelength filter with 
30 nm bandwidth in log mode, and propidium iodide fluorescence with a 585 nm filter 
and 42 nm bandwidth in linear mode.  Data acquisition was done using Lysis II software 
(version 2.0, BD Biosciences).  Fluorescence spill-over was removed by compensation.  
Photomultiplier sensitivity was adjusted so that control cell FL1 fluorescence appeared in 
the first log, and PI fluorescence at approximately 200 counts (Figure 11).  At least ten 
thousand events were acquired per sample.  Data analysis was performed using WinMDI 
software (Joseph Trotter, The Scripps Research Institute, La Jolla, CA, available online 
from http://facs.scripps.edu).  Apoptotic and necrotic cells were differentiated by plotting 
PI fluorescence over fluorescein in a bivariate plot.  Quadrants were set to define 
TUNEL-negative cells with normal DNA content; TUNEL-positive cells were counted as 
apoptotic, TUNEL-negative cells with lower DNA content as necrotic. 
5. Inactivation of Melanoma Cells by FE-DBD 
Melanoma cancer cell lines were treated on day 3 after initial seeding.  Both control and 
treated cells were cultured in aluminum dishes.  Immediately after seeding, there is an 
increase in the percentage of inactive cells but they return to their normal life cycle on 
day 3.  Proliferation of the cells continue for 5 more days at which point their numbers 
become overwhelmingly high and the cells start to die (Figure 2).  Melanoma cell growth 
patterns are important to note, because the inactivation results reported here are not due 
to lack of nutrition, cell age, or the influence of aluminum substrate on the cell’s life 
cycle.  Figure 3 demonstrates cell survival numbers after 5, 10, 20, and 30 seconds of 
treatment compared to control analyzed by Trypan blue exclusion test (Figure 4).  Total 
cell numbers are normalized to 1 (100%) to account for cell growth between the counting 
sessions: controls are set to 100% and cell viability is expressed as percent to control to 
allow for comparison between experiments.  It is of no great surprise that FE-DBD 
plasma is able to kill cells; what is unusual is that 24 hours following treatment the total 
number of cells continues to decrease significantly (Figure 3).  This is potentially 
indicative of some internal biochemical processes taking place that FE-DBD plasma 
treatment had initiated, for example apoptosis or similar cell behavior. 
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Figure 3. Results of FE-DBD treatment of Melanoma cancer cells: Control, 5, 10, 20, and 
30 seconds, counted 1, 3, and 24 hours post-treatment. 
 
 
Figure 4. Trypan blue exclusion test - blue cells (dark spots) have taken up the dye, 
indicating compromised cell membrane and are considered dead. Treatment time: 5 
seconds. 
It is important to distinguish between cell death by “poisoning” of the growth media the 
cells are in and the actual effect of direct plasma on these cells.  The ability of plasma to 
increase acidity of the treated liquid is well known (see [25, 61], for example), and 
changing pH of the growth media is known to disrupt cell functions like metabolism, 
growth, etc [2, 60].  To assess the difference, growth media was treated by plasma 
separately to change its pH and then the cells were placed in this acidified media.  Thirty 
seconds of FE-DBD treatment of media (same volume as is used for cell growth) changes 
its pH from the biologically suitable 8.5 to deadly-to-cells 5.5 (Figure 5).  As can be seen 
from Figure 6, cells placed in this acidified media survived the process and the cells 
treated by plasma in the same volume of liquid were inactivated rapidly.  Thus, we can 
assume that major effect of plasma on Melanoma cells is not through “poisoning” the 
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growth media. Moreover, Melanoma cancer cells can withstand pH drop to 5.5 for a 
period that is quite longer than what is considered deadly for other mammalian cells (see 
[1, 60, 62], for example).  Additionally, cell inactivation under varying depths of growth 
media was investigated.  Varying depths of liquid can potentially protect the cells that are 
attached to the bottom of the dish during the short treatment times employed.  Figure 7 
clearly shows that even though, as expected, liquid protects the cells from plasma, the 
treatment is able to penetrate through nearly a half of a millimeter of the growth media. 
 
Figure 5. Change of pH of the cell growth media treated with FE-DBD plasma 0 to 30 
seconds. 
 
Figure 6. Percent of dead cells in control, cell placed in acidified media for 1 minute (pH 
5.4), and cells treated by FE-DBD plasma for 10 seconds. 
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Figure 7. Results of the FE-DBD treatment of Melanoma cells protected by varying 
depths of cell growth media (liquid). 
6. Melanoma Cell Apoptotic Behavior 
Melanoma cells, treated by plasma, immediately show evidence of cell necrosis – an 
expected outcome in the tradition of the recent trend of surface sterilization by plasma 
(see [35, 63-68] for example).  However, the remaining cells that survived the treatment 
do not behave as the untreated cells do.  The general trend observed in treated cells is that 
they continue to die for days after the treatment.  Figure 8 presents an observation of 
groups of cells treated by plasma for 5 seconds and observed for a 3-day period following 
treatment.  An emergent pattern appears where growth rate of treated cells is impaired as 
well as the number of inactivated cells grows substantially.  Figure 9 shows the 
percentage of inactivated (dead) cells among treated and untreated populations.  Thus, it 
was observed that 5 seconds of plasma treatment does not inactivate cells immediately; 
however, cell growth slows down significantly, and the number of dead cells increases 24 
hours after treatment, which is indicative of cell death occurring long after the treatment. 
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Figure 8. Results of observation of treated and untreated cells for a three-day period: total 
number of cells before and after FE-DBD treatment. Treatment time: 5 seconds. 
 
 
Figure 9. Results of observation of treated and untreated cells for a three-day period: 
percent of dead cells before and after FE-DBD treatment. Treatment time: 5 seconds. 
To analyze whether those plasma-treated cells that survive the initial insult die through an 
apoptosis-like process, TUNEL assays were performed.  Cells treated for 5 seconds were 
then incubated and stained for DNA fractionation 24 hours later.  Following the TUNEL 
assay procedure (see Section 4 above) it was observed that a significant percentage of 
these cells exhibit apoptotic behavior as is evident from Figure 10.  The results of the 
flow cytometry tests performed 24, 48, and 72 hours following treatment are presented in 
Figure 11.  Apoptosis develops 24 hours following treatment, where 25.5% of cells are 
present in the treated group, compared with 2.2% in the control group.  As time 
progresses, even more cells undergo apoptosis, further reaching 72.8% of apoptotic cells 
in the treatment group vs. 3.2% in the control group 72 hours following treatment. 
  
Figure 10. Images of treated and untreated Melanoma cancer cells stained following 
TUNEL assay protocol. All cells are stained blue (darker circles) and apoptotic cells are 
also stained green (bright spots). Treatment time: 5 seconds; assay performed 24 hours 
following treatment. 
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Figure 11. Results of flow cytometry of the treated and untreated Melanoma cancer cells 
stained following TUNEL assay protocol. Treatment time: 5 seconds; assay performed 24 
(a), 48 (b), and 72 (c) hours following treatment. The FL1 (fluorescein) fluorescence 
histogram (number of events over fluorescence intensity) of a representative experiment 
is shown.  Increased fluorescence intensity in treated cells is indicative of apoptotic DNA 
cleavage. 
7. Conclusion 
Floating Electrode Dielectric Barrier Discharge (FE-DBD) plasma was shown to kill 
Melanoma skin cancer cells through necrosis at higher treatment doses (15 seconds and 
over at 1.4 Watt/cm2 of plasma treatment) which are still below the threshold of 
damaging healthy tissue [16].  Very low doses of FE-DBD (5 seconds at 0.8 Watt/cm2 of 
plasma treatment) where no cell necrosis was observed were shown to initiate apoptotic 
behavior, or programmed cell death in Melanoma cancer cells.  During apoptosis, cells 
undergo a series of complex biochemical changes leading to cell death without causing 
inflammation.  Apoptotic behavior was deduced from the fact that treated cells do not 
initially die but stop growth and die en masse 12 to 24 hours following treatment, while 
untreated cells continue to grow and proliferate.  Apoptotic behavior was confirmed 
through DeadEnd™ Fluorometric TUNEL System apoptosis staining with subsequent 
flow cytometry.  It was shown that the plasma treatment initiates this behavior in cells not 
through poisoning of the growth media in which the cells reside or through interaction 
with the aluminum dishes the cells reside in, but through direct interaction with the cells. 
Previously it was shown by authors [16] and by other groups (see [35, 63-71]) that 
plasma is able to destroy cells; however, it was also observed that plasma might be able 
to initiate or catalyze some biochemical processes in biological systems.  This is an initial 
step toward understanding mechanisms by which non-thermal atmospheric pressure 
discharge in direct contact with cells is able to influence their activity.  Previous and 
presented results may be promising, but quite a few unanswered questions remain.  
Deeper understanding of plasma-cell interaction and of the specific biochemistry is 
needed to answer how plasma promotes apoptotic behavior.  It is important to separate all 
of the effects and constituents of plasma in direct contact with cells and to analyze these 
constituents individually as well as to study synergetic effects of and between different 
plasma components to potentially receive further insight into the plasma-chemical 
interaction mechanisms.  Understanding of the apoptotic biochemical pathways invoked 
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by plasma, which species generated by plasma are able to invoke these pathways, and 
how these mechanisms are invoked is also essential.  Future work will primarily address 
fundamental understanding of plasma interaction with living tissue and physical and 
biochemical mechanisms thereof, for example effect of various plasma-generated excited 
species on the cell membrane and membrane proteins. 
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